Management of Hypothyroidism through Ayurveda

An Open Label Randomized Clinical Study to Evaluate the Efficacy of Virechana and Nasya followed by Dhananjaya Vati in the Management of Dhatwagnimandya with special reference to Hypothyroidism

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/02/017841

Enrollment

Registered

2019-02-27

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

Intervention1: GROUP A: Virechana Karma followed by Dhananjaya Vati 2 tabs B.D. (2gram) before meal with Luke warm water for 30 days. Intervention2: GROUP B: Nasya Karma followed by Dhananjaya Vati 2

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed cases of Hypothyroidism on the basis of Serum TSH, T3 and T4 levels. TSH level above 4.5 mU/L up to 100 mU/L Total Serum T4 level less than 4.5 to 12.5 ng/dl Total serum T3 level less than 80 to 220 ng/dl 2. Patients having clinical features of Hypothyroidism. 3. Patient indicated for Virechana and Nasya. 4.Patient willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Patients with any chronic and severe systemic disorders like IHD, CVA, Goiter, Uncontrolled Diabetes, CRF, Active malignant disease etc. 2. Pregnancy and lactation. 3. Patient contraindicated for Virechana and Nasya.

Design outcomes

Primary

Measure	Time frame
Reduction in TSH levelTimepoint: 75 days	—

Secondary

Measure	Time frame
1. Increased T3, level 2. Increased T4, level 3. Improved quality of lifeTimepoint: 75 days	—

Countries

India

Contacts

Public ContactDr Gopesh Mangal

National Institute of Ayurveda, jaipur

gmangal108@gmail.com8619849011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026